rivastigmine has been researched along with Nausea in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (50.00) | 29.6817 |
2010's | 7 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, D; Feng, T; Ji, Y; Jia, J; Kuang, W; Li, Y; Liang, Z; Ning, Y; Peng, D; Wei, W; Xiao, S; Ye, Q | 1 |
Cho, AH; Kim, JS; Lim, EY; Yang, DW | 1 |
Dening, T; Pinner, G; Wu, S; Xia, J; Yang, D; Yu, A; Zhang, Z; Zhao, S | 1 |
Deardorff, WJ; Grossberg, GT; Nieto, RA | 1 |
Bhatnagar, V; Brannan, S; Koumaras, B; Meng, X; Olin, JT; Reyes, P | 1 |
Darreh-Shori, T; Jelic, V | 1 |
Pregelj, P | 1 |
Aarsland, D; Albanese, A; Byrne, EJ; De Deyn, PP; Deuschl, G; Durif, F; Emre, M; Kulisevsky, J; Lane, R; Lees, A; Poewe, W; Quarg, P; Robillard, A; Rosa, MM; Tekin, S; van Laar, T; Wolters, E | 1 |
Press, DZ | 1 |
Harada, CN; Sachs, GA; Shega, JW | 1 |
Morgan, J; Sethi, KD | 1 |
Wesnes, K | 1 |
Landmark, K; Reikvam, A | 1 |
Allison, M; Appel-Dingemanse, S; Ho, YY; Huang, HL; Kiese, B; Lefèvre, G; Pommier, F; Sedek, G | 1 |
3 review(s) available for rivastigmine and Nausea
Article | Year |
---|---|
Cholinesterase inhibitors for the treatment of delirium in non-ICU settings.
Topics: Aged, 80 and over; Cholinesterase Inhibitors; Delirium; Female; Humans; Length of Stay; Male; Nausea; Rivastigmine | 2018 |
Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia.
Topics: Administration, Cutaneous; Administration, Oral; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Dermatitis, Irritant; Humans; Nausea; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome; Vomiting | 2010 |
Rivastigmine tartrate with a focus on dementia associated with Parkinson's disease.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Humans; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine; Tremor; Vomiting | 2007 |
4 trial(s) available for rivastigmine and Nausea
Article | Year |
---|---|
Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer's Disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Female; Humans; Male; Middle Aged; Nausea; Rivastigmine; Severity of Illness Index; Treatment Outcome; Vomiting | 2019 |
Rivastigmine for dementia associated with Parkinson's disease.
Topics: Aged; Cholinesterase Inhibitors; Dementia; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine; Tremor; Vomiting | 2004 |
Rivastigmine for dementia associated with Parkinson's disease.
Topics: Aged; Cholinesterase Inhibitors; Dementia; Dose-Response Relationship, Drug; Female; Humans; Male; Mental Disorders; Middle Aged; Nausea; Neuroprotective Agents; Parkinson Disease; Patient Selection; Phenylcarbamates; Prospective Studies; Rivastigmine; Treatment Outcome; Tremor; Vomiting | 2005 |
Pharmacokinetics and bioavailability of the novel rivastigmine transdermal patch versus rivastigmine oral solution in healthy elderly subjects.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Area Under Curve; Benzylamines; Biological Availability; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Cross-Over Studies; Dizziness; Female; Half-Life; Headache; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Phenethylamines; Phenols; Phenylcarbamates; Rivastigmine; Sleep Initiation and Maintenance Disorders; Solutions; Tandem Mass Spectrometry; Vomiting | 2008 |
7 other study(ies) available for rivastigmine and Nausea
Article | Year |
---|---|
Safety and Efficacy of Anti-dementia Agents in the Extremely Elderly Patients with Dementia.
Topics: Activities of Daily Living; Aged, 80 and over; Alzheimer Disease; Donepezil; Exanthema; Female; Humans; Indans; Male; Medication Adherence; Nausea; Neuropsychological Tests; Nootropic Agents; Piperidines; Retrospective Studies; Rivastigmine; Treatment Outcome | 2018 |
Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Humans; Nausea; Rivastigmine; Transdermal Patch; Vomiting | 2016 |
Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32).
Topics: Activities of Daily Living; Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Antiparkinson Agents; Blood Pressure; Capsules; Cholinesterase Inhibitors; Cognition; Dizziness; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Humans; Incidence; Male; Memantine; Middle Aged; Nausea; Phenylcarbamates; Pilot Projects; Prospective Studies; Rivastigmine; Vomiting | 2010 |
Safety and tolerability of rivastigmine transdermal patch formulation in newly diagnosed patients with Alzheimer's dementia in naturalistic conditions.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Dermatitis, Contact; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neuropsychological Tests; Patient Compliance; Phenylcarbamates; Prospective Studies; Rivastigmine; Transdermal Patch; Treatment Outcome; Vomiting | 2012 |
Parkinson's disease dementia--a first step?
Topics: Antiparkinson Agents; Cholinesterase Inhibitors; Dementia; Disease Progression; Humans; Lewy Body Disease; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine | 2004 |
Rivastigmine for dementia associated with Parkinson's disease.
Topics: Bias; Cholinesterase Inhibitors; Data Interpretation, Statistical; Dementia; Humans; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine; Tremor; Vomiting | 2005 |
[Rivastigmine against dementia in Parkinson disease?].
Topics: Cholinesterase Inhibitors; Dementia; Humans; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine; Vomiting | 2007 |